AU2012905072A0 - The use of bucillamine in the treatment of gout - Google Patents
The use of bucillamine in the treatment of goutInfo
- Publication number
- AU2012905072A0 AU2012905072A0 AU2012905072A AU2012905072A AU2012905072A0 AU 2012905072 A0 AU2012905072 A0 AU 2012905072A0 AU 2012905072 A AU2012905072 A AU 2012905072A AU 2012905072 A AU2012905072 A AU 2012905072A AU 2012905072 A0 AU2012905072 A0 AU 2012905072A0
- Authority
- AU
- Australia
- Prior art keywords
- bucillamine
- gout
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- VUAFHZCUKUDDBC-SCSAIBSYSA-N (2S)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid Chemical compound CC(C)(S)C(=O)N[C@H](CS)C(O)=O VUAFHZCUKUDDBC-SCSAIBSYSA-N 0.000 title 1
- 229960004272 bucillamine Drugs 0.000 title 1
- 201000005569 gout Diseases 0.000 title 1
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020157012177A KR20150084833A (en) | 2012-11-20 | 2013-11-19 | The use of bucillamine in the treatment of gout |
| US14/443,639 US9238018B2 (en) | 2012-11-20 | 2013-11-19 | Use of bucillamine in the treatment of gout |
| PCT/CA2013/050882 WO2014078956A1 (en) | 2012-11-20 | 2013-11-19 | The use of bucillamine in the treatment of gout |
| CA2888647A CA2888647A1 (en) | 2012-11-20 | 2013-11-19 | The use of bucillamine in the treatment of gout |
| EP13856562.7A EP2922536A4 (en) | 2012-11-20 | 2013-11-19 | The use of bucillamine in the treatment of gout |
| JP2015542127A JP2015537009A (en) | 2012-11-20 | 2013-11-19 | Use of bucillamine in the treatment of gout |
| US14/855,951 US9662305B2 (en) | 2012-11-20 | 2015-09-16 | Use of bucillamine in the treatment of gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2012905072A0 true AU2012905072A0 (en) | 2012-12-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1209413A1 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof 5--2- | |
| HK1207860A1 (en) | 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3- | |
| EP2922536A4 (en) | The use of bucillamine in the treatment of gout | |
| EP2867239A4 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes | |
| HK1210585A1 (en) | Alpha-1-microglobulin for use in the treatment of mitochondria- related diseases -1 | |
| HK1209639A1 (en) | Gpbp-1 inhibition and its therapeutic use gpbp-1 | |
| ZA201504405B (en) | 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof | |
| PT2875026T (en) | Imidazopyridine derivative used in the treatment of diabetes | |
| SI2872176T1 (en) | Carboranylporphyrins for use in the treatment of cancer | |
| GB2515440B (en) | Vesicular Formulations for use in the treatment of Rosacea | |
| HK1209033A1 (en) | Use of odiparcil in the treatment of mucopolysaccharidosis | |
| AU2012905072A0 (en) | The use of bucillamine in the treatment of gout | |
| LT2863932T (en) | Composition for use in the treatment of lymphedema | |
| EP3071207A4 (en) | Libido-enhancing therapeutic and use | |
| ME03635B (en) | 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof | |
| AU2012903508A0 (en) | Breast-protective orthosis and use thereof | |
| AP2015008228A0 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| AU2012903356A0 (en) | Improvements in Medical Treatment | |
| AU2012900796A0 (en) | Pain treatment |